Zacks reiterated their neutral rating on shares of Zimmer Holdings (NYSE: ZMH) in a research report sent to investors on Friday morning. The firm currently has a $80.00 price target on the stock.
Zacks’ analyst wrote, “Zimmer’s fourth quarter adjusted EPS of $1.51 was ahead of the Zacks Consensus Estimate by $0.02 and the year-ago $1.36. Revenues were $1.18 billion, up 2.1% at CER and ahead of the Zacks Consensus Estimate of $1.175 billion. Pricing pressure continues to remain a major headwind for the company. Moreover, currency headwind in 2013 is expected to reduce revenues by 0.5%. However, we are encouraged to note improving sales in the emerging markets like Asia Pacific that offers significant growth opportunities for the company’s reconstructive business. Meanwhile, Zimmer is on its way to achieve market growth based on its strong product portfolio and ageing demographics. In order to streamline its business, Zimmer plans to continue with its global restructuring program. As a result, we maintain our Neutral’ recommendation.”
Zacks has also taken action a number of other healthcare stocks recently. The firm upgraded shares of Cutera from a neutral rating to an outperform rating. The firm now has a $12.70 price target on that stock. Also, Zacks downgraded shares of Nxstage Medical from an outperform rating to a neutral rating. Their analysts now have a $14.00 price target on that stock. Finally, Zacks upgraded shares of Medical Action Industries from a neutral rating to an outperform rating. Zacks now has a $6.20 price target on that stock.
Other equities research analysts have also recently issued reports about the stock. Analysts at Argus upgraded shares of Zimmer Holdings from a hold rating to a buy rating in a research note to investors on Wednesday, February 13th. They now have a $90.00 price target on the stock. Separately, analysts at Barclays Capital raised their price target on shares of Zimmer Holdings from $73.00 to $81.00 in a research note to investors on Friday, February 1st. They now have an overweight rating on the stock. Finally, analysts at Canaccord Genuity raised their price target on shares of Zimmer Holdings from $78.00 to $87.00 in a research note to investors on Friday, February 1st.
Ten equities research analysts have rated the stock with a buy rating, two have issued an overweight rating, twenty-one have assigned a hold rating, and one has assigned a sell rating to the company. The company currently has an average rating of overweight and an average target price of $77.87.
Shares of Zimmer Holdings traded up 0.28% during mid-day trading on Friday, hitting $76.11. Zimmer Holdings has a one year low of $57.46 and a one year high of $76.75. The stock’s 50-day moving average is currently $72.94. The company has a market cap of $13.152 billion and a P/E ratio of 17.69.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.
